Brain tissue sections from AD patients as well as other tauopathies, such as Pick’s disease, corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), have been shown to be immunopositive for molecular chaperones (Hsp90, Hsp70, and their cochaperones) as well as the Chip ubiquitin ligase (25,38,59)

Brain tissue sections from AD patients as well as other tauopathies, such as Pick’s disease, corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), have been shown to be immunopositive for molecular chaperones (Hsp90, Hsp70, and their cochaperones) as well as the Chip ubiquitin ligase (25,38,59). selective appearance of insoluble amyloid 42 (A42), suggesting an essential role for Hsp110 in APP processing and A generation. Thus, our findings providein vivoevidence that Hsp110 plays a critical function in tau phosphorylation state through maintenance of efficient PP2A activity, confirming its role in pathogenesis of Alzheimer’s disease and other tauopathies. Diseases like Alzheimer’s disease (AD) and other tauopathies are defined by the expression of neurofibrillary tangles (NFTs) deposited mainly in neurons. The NFTs are aggregates of the hyperphosphorylated tau (p-tau) (3,74). Normal tau increases microtubule stability, but tau can be hyperphosphorylated under disease PhiKan 083 hydrochloride conditions and released from microtubules (3,5,6). The molecular mechanisms involved in the formation of NFTs are not completely understood. However, accumulation of abnormal p-tau and NFTs causes neurodegeneration (3). A number of protein kinases, including glycogen synthase kinase 3 (GSK3) and cyclin-dependent protein kinase 5 (CDK5), have been shown to phosphorylate tau at Thr231 and Ser262 as well as several other sites that flank the microtubule binding repeat, leading to tangles of paired helical filaments (PHFs) similar to those observed in the brains of PhiKan 083 hydrochloride patients with AD (54,72). Evidence shows that GSK3 physically interacts with tau and is thought to be the main contributor to the formation of NFTs and amyloid (A) plaques in AD patients (18,53,54). Phosphorylation of GSK3a/b at S9/S21 which is inhibitory to its activity during Rabbit Polyclonal to PTGIS insulin signaling, leads to phosphorylation of tau in neurons (80). GSK3a/b phospho-S9/S21, p-tau, and 14-3-3zeta have been isolated in a 500-kDa complex, and the interaction has been shown to result in tau phosphorylation by GSK3 (1,80). Although not well characterized, p-tau has been shown to be dephosphorylated by the B family regulatory subunit of the heterotrimeric PP2A holoenzyme (76). There are two protein phosphatase 2A (PP2A) binding sites on microtubule tau binding repeats, perhaps allowing tau to be more efficiently dephosphorylated by PP2A catalytic subunit (76). Both GSK3 and CDK5 are also known to be involved in the phosphorylation of amyloid precursor protein (APP) at Thr668 and APP processing and A production (53,58). PhiKan 083 hydrochloride Studies suggest that amyloid peptide can activate GSK3 signaling, and the increase in GSK3 activity can then contribute to abnormal APP processing. Indeed, reduction in GSK3 activity reduces amyloid peptide production in murine AD models (18,53,57,71). Reduction in PP2A activity leads to altered APP regulation as well (26,43). Additional molecules that affect tau hyperphosphorylation and APP processing are the peptidyl prolyl isomerases (9,36,51). Deletion of Pin1 isomerasein vivoleads to p-tau and neurodegeneration (42). Crossing Pin1-deficient mice with transgenic mice expressing mutant APP (APPsw) leads to abnormal APP processing and accumulation of toxic amyloid 42 (A42) species. Pin1, therefore, PhiKan 083 hydrochloride is implicated in isomerization of tau, perhaps facilitating its dephosphorylation (42). The presence of Pin1 has been implicated in promoting nonamyloidogenic processing of APP and reduction in toxic A42 production (51). Hsp70/Hsc70 has been shown to preferentially bind to a hyperphosphorylated form of tau in the diseased human brain (49). Cross talk between the ubiquitin proteasome system (UPS) and molecular chaperones might also be critical in regulating the deposition and toxicity of tau (8,16). These results suggest that the activity of Hsp70 and Hsp90 preserve the native structure and function of tau protein. Hsp70 and the C-terminal Hsp70-interacting protein (Chip) have been shown to regulate tau ubiquitination and degradation (11,12,21,52,65). Interestingly, Chip and APP interact, and Chip and Hsp70/90 expression have been shown to lower the cellular levels of A and reduce A toxicityin vitro(39). Misfolded proteins are either degraded through the UPS or are folded, at least in part, by the Hsps (4,7). Eukaryotic cells possess a class of heat shock proteins (Hsps) related to.